Mesothelin-family proteins and diagnosis of mesothelioma

30/03/2016
Author:  Robinson BW - Creaney J; Lake R et al.

Robinson BW, Creaney J, Lake R, et al.
Lancet. 2003; 362(9396):1612-1616.

This publication investigated the serum concentrations of the MESOMARK assay (SMRP) in a group of patients diagnosed with mesothelioma, diagnosed with other cancers, presenting with pleural fluid not related to mesothelioma, diagnosed with lung inflammatory disease and healthy controls.

Results showed that patients diagnosed with mesothelioma had increased concentrations of SMRP compared to patients who were asbestos exposed and the non-asbestos exposed controls. This research also correlated tumor mass with SMRP concentration, in which the concentrations of SMRP are elevated in patients with the largest tumor mass. The authors propose that the use of the SMRP serum value could be useful as an aid in the monitoring of tumor growth.

CLOSE

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Please log in to react

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.